Affiliation:
1. Birla Institute of Technology
2. University of Miami
3. Kalinga Institute of Industrial Technology (KIIT) University
4. Institute of Life Sciences
5. Indian Institute of Technology Kharagpur
Abstract
Abstract
Frequent mutation and variable immunological protection against vaccination is a common feature for COVID-19 pandemic. Early detection and confinement remain key to controlling further spread of infection. In response, we have developed an aptamer-based system that possesses both diagnostic and therapeutic potential towards the virus. A random aptamer library (~ 1017 molecules) was screened using systematic evolution of ligands by exponential enrichment (SELEX) and aptamer R was identified as a potent binder for the SARS-CoV-2 spike receptor binding domain (RBD) using in vitro binding assay. Using a pseudotyped viral entry assay we have shown that aptamer R specifically inhibited the entry of a SARS-CoV-2 pseudotyped virus in HEK293T-ACE2 cells but did not inhibit the entry of a Vesicular Stomatitis Virus (VSV) glycoprotein (G) pseudotyped virus, hence establishing its specificity towards SARS-CoV-2 spike protein. The antiviral potential of aptamers R and J (same central sequence as R but lacking flanked primer regions) was tested and showed 95.4% and 82.5% inhibition, respectively, against the SARS-CoV-2 virus. Finally, intermolecular interactions between the aptamers and the RBD domain were analyzed using in silico docking and molecular dynamics simulations that provided additional insight into the binding and inhibitory action of aptamers R and J.
Publisher
Research Square Platform LLC
Reference43 articles.
1. WHO WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (accessed 24 July 2022).
2. Decoding SARS-CoV-2 transmission and evolution and ramifications for COVID-19 diagnosis, vaccine, and medicine;Wang R;Journal of chemical information and modeling,2020
3. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin DR;The Lancet,2022
4. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients;Pan Y;Journal of Infection,2020
5. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin DR;The Lancet,2022